Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Infographics

For coronavirus patients, and all patients, being without a bed means being without a place to go.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

It’s senior leadership’s job — including board members — to mitigate the effects of this pandemic.

Partner, Health & Life Sciences, Oliver Wyman
Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Evaluating healthcare workforce supply and demand.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Five things for payers to keep in mind as they look to tap into the booming primary care market.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

Specialty drugs represent an opportunity to better serve patients, but also pose risks.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Actuarial, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

The recent rise of custom-made drugs is already redefining the state of regulation, society, and the economy.

Researcher, PreScouter

A one-size-fits-all SDOH approach isn't the answer. Yet it's the industry norm.

Executive Founder, Wellville
Partner, Health & Life Sciences, Oliver Wyman

Here's how we did on last year's predictions and what emerging trends to expect next.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Manager, Health & Life Sciences, Oliver Wyman

In our rearview mirror is a ten-year stretch of experimentation. What looms ahead is the rewriting of healthcare's rules.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Five workstreams to help leaders adopt a new organizational approach.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Head Leadership and Organizational Performance, Mercer

Insights in your inbox

Subscribe